Blog
Illumina Cybersecurity Vulnerability May Present Risks for Patient Results and Customer Networks
FDA Safety Communication for Patients and Healthcare Providers on NIPS
FDA Control of Laboratory Developed Tests (LDTs) Building Momentum with VALID Act
Natera and CareDx Fined Millions for False Advertising Associated with Inappropriate Marketing for Testing
